David Young, President Research & Development at Processa Pharmaceuticals, Inc. (PCSA), bought 40,000 shares at $2.53 ($101K) on 2024-02-06, disclosed to the SEC on 2024-02-07.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.53 | 20,000 | $51K | 50.0% |
| 2 | $2.53 | 20,000 | $51K | 50.0% |
| Total | $2.53 avg | 40,000 | $101K | 100% |
| Filing → |
| PCSA | BUY | 2026-06-01 | $5K | — | Filing → |
| PCSA | BUY | 2026-05-19 | $5K | — | Filing → |
| PCSA | BUY | 2026-05-01 | $5K | — | Filing → |